NewLink Genetics Corp. | Key People and Executives
Charles J. Link
Chairman, Chief Executive & Scientific Officer
Nicholas N. Vahanian
President & Director
Matthew L. Sherman
Director
Chad A. Johnson
Independent Director
Paolo Pucci
Independent Director
Tom A. Raffin
Lead Independent Director
Lota S. Zoth
Independent Director
Ernest Joseph Talarico
Independent Director
Charles J. Link
Chairman, Chief Executive & Scientific Officer
Nicholas N. Vahanian
President & Director
Carl W. Langren
Chief Financial Officer
Eugene P. Kennedy
Chief Medical Officer
John B. Henneman
Chief Administrative Officer
Lori Lawley
CAO, Vice President-Finance & Controller
Jun Zhao
Vice President-Quality & Compliance
Matthew L. Sherman
Director
Lisa Wells Miller
Director-Investor Relations
Brad Powers
General Counsel
Lisa V. DeLuca
Vice President-Regulatory Affairs
Chad A. Johnson
Independent Director
Paolo Pucci
Independent Director
Thomas A. Raffin
Lead Independent Director
Lota S. Zoth
Independent Director
Ernest Joseph Talarico
Independent Director
| Address |
2503 South Loop Drive
Ames Iowa 50010
United States
|
|
Employees
|
- |
| Website |
http://www.newlinkgenetics.com |
| Updated |
07/08/2019 |
| NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. |
